---
title: "Elixir Medical submits approval for DynamX coronary bioadaptor in Japan"
date: "2023-10-09T14:40:50.000Z"
publishedDate: "9 octobre 2023"
summary: "Elixir Medical has announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX coronary bioadaptor system for the treatment of coronary artery disease (CAD). DynamX coronary bioadaptor was developed to overcome the limitations of drug-eluting stents (DES) and bioresorbable scaffolds (BRS)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/dynamx-pmda-approval-submission/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-10-09-elixir-medical-submits-approval-for-dynamx-coronary-bioadaptor-in-japan"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/DynamX-expanded-in-vessel-WEB.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dynamx-pmda-approval-submission/"
---

![Elixir Medical submits approval for DynamX coronary bioadaptor in Japan](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/DynamX-expanded-in-vessel-WEB.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dynamx-pmda-approval-submission/*

## L’essentiel

Elixir Medical has announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX coronary bioadaptor system for the treatment of coronary artery disease (CAD). DynamX coronary bioadaptor was developed to overcome the limitations of drug-eluting stents (DES) and bioresorbable scaffolds (BRS).

## Lien source

https://cardiovascularnews.com/dynamx-pmda-approval-submission/
